| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 59.85 | 27.8% |
| Total Income | 60.90 | 27.1% |
| Expenditure | 55.16 | 27.0% |
| PBT | 5.74 | 26.3% |
| Net Profit | 4.19 | 27.9% |
| OPM | 9.67% | 0.32pp |
| NPM | 6.88% | 0.08pp |
| EPS | 0.82 | 28.1% |
Black Rose Industries Ltd Reports Q1 FY26 Results: Revenue and Profits Down, Manufacturing Business Thrives
22 Aug 2025 · 22 Aug 2025, 03:15 pm
Summary
Black Rose Industries Ltd has reported its Q1 FY26 results. The company's overall revenue and profits have declined compared to the previous quarter, mainly due to supply constraints in key distribution products and slower demand. However, the manufacturing business posted significantly higher sales and profits versus the corresponding quarter last year, driven by broader product offerings and expanded market reach.
Key Highlights
- 1
Revenue for Q1 FY26 is Rs. 60.89 crores, down 26.6% from Q4 FY25 and down 19.0% from Q1 FY25.
- 2
EBITDA for Q1 FY26 is Rs. 6.89 crores, down 24.3% from Q4 FY25 and down 3.8% from Q1 FY25.
- 3
PBT for Q1 FY26 is Rs. 5.79 crores, down 27.1% from Q4 FY25 and down 8.3% from Q1 FY25.
- 4
PAT for Q1 FY26 is Rs. 4.24 crores, down 29.0% from Q4 FY25 and down 9.4% from Q1 FY25.
- 5
Manufacturing business posted significantly higher sales and profits versus the corresponding quarter last year.
- 6
Distribution division recorded a 37% decline in turnover compared to the previous quarter.
- 7
Acrylamide liquid sales are expected to increase in both domestic and export markets.
- 8
Company anticipates a significant increase in sales volumes and margins for key products in the upcoming quarter.
- 9
Impact of US tariffs is expected to be minimal due to the company's diversified product portfolio and extensive market reach.
Management Comments
Ambarish Daga
The manufacturing division recorded a strong improvement in Q1 FY26 compared to the corresponding quarter of the previous year, supported by higher volumes from acrylamide liquid and N-methylol acrylamide. Although overall sales were marginally lower versus Q4 FY 25, the division maintained a steady performance on the back of stable demand across key products. The company remains the sole global manufacturer of acrylamide solid outside of China. Sales during Q1 FY26 were steady compared to the previous quarter and higher than the corresponding quarter of the prior year. Regular orders from domestic customers continued during the period, even as Chinese manufacturers maintained steady supply, underscoring the company’s established position in the market.
Informational and educational content only. Not investment advice.